Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update
- PMID: 36400561
- DOI: 10.1016/j.ncl.2022.05.004
Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update
Abstract
Multiple sclerosis (MS) is the most prevalent nontraumatic disabling neurologic condition among young adults worldwide. The diagnosis and management of MS is complex. The goal of this review is to provide an updated and practical approach to the diagnosis and treatment approaches in MS, emphasizing current understanding of immunopathogenesis, recent advances, and future directions, for both MS and non-MS clinicians.
Keywords: Central nervous system; Demyelination; Diagnosis; Multiple sclerosis; Treatment.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure C.A. Pérez received postgraduate fellowship support from Genentech and has participated in advisory boards for Sanofi. F.X. Cuascut received research funding from Genentech and Biogen and has participated in advisory boards for Genentech, Biogen, Horizon, and Pharma Novartis and Horizon. G.J. Hutton received research funding from Biogen, Hoffman-La Roche, Sanofi, MedImmune, and Novartis and has participated in advisory boards for Novartis and Horizon.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical